not losing weight tirzepatide Why Am I on Tirzepatide? Why are you not Losing

SUSTAIN 6, in particular, included patients with type 2 diabetes who also had CVD, chronic kidney disease, or both

In a clinical trial called SUSTAIN-6, Semaglutide was found to significantly reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death, compared to a placebo

Key takeaways: Retatrutide reduced moderate-to-severe OSA severity by up to 36.1 events per hour (60.6%) from a baseline of 58.6 events per hour

Zinman et al., 2018)

You place the pen against your skin, hold it firmly in place, and keep holding until the injection has finished, normally 5-10 seconds